Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Status:
Recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether perioperative intravenous administration of
pantoprazole will improve kidney function parameters following cardiac surgery with
cardiopulmonary bypass compared to famotidine and to determine whether perioperative
intravenous administration of pantoprazole will decrease the incidence of postoperative Acte
Kidney Injury (AKI) and major adverse kidney events (MAKE).
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston